Prospective Evaluations of Infectious Complication in Lung Transplant Recipients

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Active, Not Recruiting to Completed
    • Primary and study completion dates changed from estimate of Dec 2025 to Jan 1, 2026
    v27
  2. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v26
  3. 2 versions Re-verified since May 8, 2023, no change to tracked fieldsv24-v25
  4. Site contact updatedv23
  5. 4 versions Re-verified since Jun 11, 2018, no change to tracked fieldsv19-v22
Show 17 earlier versionsHide 17 earlier versions
  1. Primary and study completion dates: Dec 2020 to Dec 2025v18
  2. 4 versions Re-verified since Jul 29, 2013, no change to tracked fieldsv14-v17
  3. Primary completion date: Dec 2020
    • Study completion date: Dec 2015 to Dec 2020
    • Site contact updated
    v13
  4. Re-verified, no change to tracked fieldsv12
  5. Study completion date: Dec 2012 to Dec 2015v11
  6. Site contact updatedv10
  7. 2 versions Re-verified since Jun 3, 2008, no change to tracked fieldsv8-v9
  8. Enrollment target: 400 to 600
    • Study completion date: Dec 2012
    v7
  9. Study description revised
    • Site contact updated
    • Collaborators shortened, about 3 words
    v6
  10. 2 versions Re-verified since Dec 14, 2006, no change to tracked fieldsv4-v5
  11. Start date: Dec 2002 to Aug 2006
    • Study completion date: Sep 2005 to not stated
    v3
  12. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary aim of this study is to determine prospectively the viral and C. pneumoniae infection prevalence and outcomes of infections in lung transplant recipients. The study will also determine the correlation of C. pneumoniae infection with the development of obliterans in lung transplant recipients.
Trial Details
NCT Number NCT00177918
Lead Sponsor University of Pittsburgh
Conditions
(from sponsor)		 Disorder Related to Lung Transplantation, Bronchiolitis Obliterans
Related terms Bronchiolitis Obliterans
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov